Business Description
InSilico Medicine Cayman TopCo
NAICS : 513210
SIC : 7373
ISIN : KYG4790P1037
Total Employee Number:
317Compare
Compare
Traded in other countries / regions
03696.Hong KongO15.Germany IPO Date
2026-01-13Description
InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. It has generated multiple clinical-stage or IND-enabling assets using Pharma.AI, an AI-enabled platform that supports drug discovery and development activities. The company operates under a project-based business model, deriving revenue from out-licensing and collaboration arrangements. Geographically, the company generates revenue from multiple countries, with the majority of the revenue coming from United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 75.06 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 51.15 | |||||
Beneish M-Score | 18.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 136.4 | |||||
3-Year EBITDA Growth Rate | -123.6 | |||||
3-Year EPS without NRI Growth Rate | -125.3 | |||||
3-Year FCF Growth Rate | -112.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 68.23 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.11 | |||||
9-Day RSI | 58.72 | |||||
14-Day RSI | 55.82 | |||||
3-1 Month Momentum % | -1.92 | |||||
6-1 Month Momentum % | -28.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.99 | |||||
Quick Ratio | 13.99 | |||||
Cash Ratio | 13.2 | |||||
Days Sales Outstanding | 59.89 | |||||
Days Payable | 444.95 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.53 | |||||
Operating Margin % | -110.21 | |||||
Net Margin % | -624.11 | |||||
EBITDA Margin % | -615.14 | |||||
FCF Margin % | -141.76 | |||||
OCF Margin % | -136.48 | |||||
ROA % | -120.54 | |||||
ROIC % | -10.65 | |||||
3-Year ROIIC % | -2.77 | |||||
ROC (Joel Greenblatt) % | -2905.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 1280 | |||||
PS Ratio | 61.93 | |||||
PB Ratio | 7.75 | |||||
Price-to-Tangible-Book | 7.72 | |||||
EV-to-EBIT | -8.66 | |||||
EV-to-EBITDA | -8.78 | |||||
EV-to-Revenue | 54 | |||||
EV-to-FCF | -37.47 | |||||
| Price-to-Net-Current-Asset-Value | 8.08 | |||||
| Price-to-Net-Cash | 8.61 | |||||
Earnings Yield (Greenblatt) % | -11.55 | |||||
FCF Yield % | -2.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InSilico Medicine Cayman TopCo Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 48.385 | ||
| EPS (TTM) (€) | -0.54 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 55.82 | ||
| 14-Day ATR (€) | 0.342177 | ||
| 20-Day SMA (€) | 4.824 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 3.58 - 9 | ||
| Shares Outstanding (Mil) | 578.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InSilico Medicine Cayman TopCo Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InSilico Medicine Cayman TopCo Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
InSilico Medicine Cayman TopCo Frequently Asked Questions
What is InSilico Medicine Cayman TopCo(FRA:O15)'s stock price today?
The current price of FRA:O15 is €5.25. The 52 week high of FRA:O15 is €9.00 and 52 week low is €3.58.
When is next earnings date of InSilico Medicine Cayman TopCo(FRA:O15)?
The next earnings date of InSilico Medicine Cayman TopCo(FRA:O15) is .
Does InSilico Medicine Cayman TopCo(FRA:O15) pay dividends? If so, how much?
InSilico Medicine Cayman TopCo(FRA:O15) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on InSilico Medicine Cayman TopCo
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers